当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Richard E. Kouri, Donald P, Warsing JR, Nikhil John Singh, Beena Thomas, Robert B. Handfield
This paper describes the utilization of a mathematical modeling tool for evaluating alternative testing cadences for the SARS-CoV-2 virus that are applicable to any well-contained congregate setting. These settings include long-term care facilities, and public-school systems.
Variables analyzed include population sizes, contagion factor, and unique testing objectives that congregate settings might have (e.g., differing susceptibilities, or varying underlying health conditions). The tool helps evaluate cost vs benefit for a range of testing cadences (e.g., daily, every 2 days, every 3 days, every week, every 2 weeks, every 3 weeks, and every 4 weeks) based on use of a commercially available antigen testing kit that costs $5 per test.
Our method allows public health officials, site managers and/or on-site healthcare workers to generate effective testing plans that align with available resources and support fact-based decision making. We also discuss how this tool can work with vaccine roll-out both in the United States and elsewhere.